Adfoj 6mg Tablet DEFLAZACORT

Introduction to Adfoj 6mg Tablet

The Adfoj 6mg Tablet is a medication primarily used to treat certain medical conditions by reducing inflammation and suppressing the immune system. It is particularly effective in managing symptoms associated with Duchenne muscular dystrophy (DMD) in children aged 5 and older.

Composition of Adfoj 6mg Tablet

The active ingredient in Adfoj 6mg Tablet is Deflazacort. This component is responsible for its therapeutic effects, helping to alleviate inflammation and modulate the immune response.

Uses of Adfoj 6mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children.
• Reduction of inflammation in various conditions.
• Suppression of the immune system to prevent overactivity.

Side effects of Adfoj 6mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions
• Severe nausea or vomiting
• Extreme tiredness
• Headache

Precautions of Adfoj 6mg Tablet

Before taking Adfoj 6mg Tablet, inform your doctor if you are allergic to it or any of its ingredients. Use with caution during pregnancy and breastfeeding. Do not stop taking the medication suddenly, as it may lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Adfoj 6mg Tablet

• Take the tablet once daily by mouth.
• The recommended dose is about 0.9 mg per kilogram of body weight.
• Can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Adfoj 6mg Tablet

The Adfoj 6mg Tablet is a valuable medication for managing conditions like Duchenne muscular dystrophy by reducing inflammation and modulating the immune system. Always follow your healthcare provider's instructions and be aware of potential side effects and precautions to ensure safe and effective use.